Q: Hi, which cannabis companies would you recommend as having good potential for high growth?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Gritstone Bio (GRTS) is a small, early-stage biotech company to which Gilead Sciences has provided some funding under an agreement announced on Feb 1, 2021:
"Under the terms of the agreement, Gilead will make a $60 million payment at closing, consisting of a $30 million upfront cash payment and a $30 million equity investment at a premium. Gilead will be responsible for conducting a Phase 1 study for the HIV-specific therapeutic vaccine and holds an exclusive option under the collaboration to obtain an exclusive license to develop and commercialize the HIV-specific therapeutic vaccine beyond Phase 1. Gritstone is also eligible to receive up to an additional $725 million if the option is exercised and if certain clinical, regulatory and commercial milestones are achieved, as well as mid single-digit to low double-digit tiered royalties on net sales upon commercialization."
GRTS share price has established a baseline after falling steadily since the funding announcement. Presumably Gilead did some due diligence before investing its own money, but the stock price could go to zero if Gilead walks away. However, it could also soar if the trials are successful. Would you consider GRTS to be a worthwhile speculative buy? What has been your experience of investing in early-stage biotech companies that have drawn the attention of Big Pharma?
"Under the terms of the agreement, Gilead will make a $60 million payment at closing, consisting of a $30 million upfront cash payment and a $30 million equity investment at a premium. Gilead will be responsible for conducting a Phase 1 study for the HIV-specific therapeutic vaccine and holds an exclusive option under the collaboration to obtain an exclusive license to develop and commercialize the HIV-specific therapeutic vaccine beyond Phase 1. Gritstone is also eligible to receive up to an additional $725 million if the option is exercised and if certain clinical, regulatory and commercial milestones are achieved, as well as mid single-digit to low double-digit tiered royalties on net sales upon commercialization."
GRTS share price has established a baseline after falling steadily since the funding announcement. Presumably Gilead did some due diligence before investing its own money, but the stock price could go to zero if Gilead walks away. However, it could also soar if the trials are successful. Would you consider GRTS to be a worthwhile speculative buy? What has been your experience of investing in early-stage biotech companies that have drawn the attention of Big Pharma?
Q: Why it go up so much today ? Thanks a million .
Q: What s your take on Xebec latest announcement?
Q: I bought VET awhile ago and am still underwater on it but am optimistic about the future. What is your view?
Q: Hi 5i,
I have been watching Alaris and waiting to buy it. Today it broke through to a new 52 week high on above average volumes (247K vs Avg of 162K). Do you think the recent investment in Vehicle Leasing Holdings is the reason for this move up or some other reason? Do you consider the time is right to pick it up now? Thanks
I have been watching Alaris and waiting to buy it. Today it broke through to a new 52 week high on above average volumes (247K vs Avg of 162K). Do you think the recent investment in Vehicle Leasing Holdings is the reason for this move up or some other reason? Do you consider the time is right to pick it up now? Thanks
Q: Peter; Can you comment on this company re expected earnings plus your overall thoughts on its future? Thanks. Rod
Q: What do you think of the mid to long term growth of POOL and SPWH?
Q: Few of my international holdings pay dividends and in trying to correct that, I thought of adding SDIV as a new holding. I have the following questions or concern:
1. Many companies held in the ETF are on not that large (for the type of internatinal business a Canadian might want to risk); and
2. SDIV also underweights quality and momentum.
Notwithstanding the above concerns, would you say the ETF is worth adding as part of one's holdings outside North America? Please comment on SDIV, but if you have other ETFs you prefer, kindly advise). Thanks
1. Many companies held in the ETF are on not that large (for the type of internatinal business a Canadian might want to risk); and
2. SDIV also underweights quality and momentum.
Notwithstanding the above concerns, would you say the ETF is worth adding as part of one's holdings outside North America? Please comment on SDIV, but if you have other ETFs you prefer, kindly advise). Thanks
Q: My KXS shares have recently doubled and haVE exceeded my arbitrary 5% holdings threshold . I have a long term view of my tech holdings but wondered if you think selling off some KXS for Topicus or LSPD (or both) is worthwhile for some added growth for the next 5 years?
I am not adverse to holding onto to KXS if you think it could revisit its historical high in the next 12 months.
Some shares are in a TFSA and some in a registered account.
Thank you for your continued support.
Kevin
I am not adverse to holding onto to KXS if you think it could revisit its historical high in the next 12 months.
Some shares are in a TFSA and some in a registered account.
Thank you for your continued support.
Kevin
Q: I've been a holder of Calibre Mining for a while, and I'm getting a little worried about its slide downhill regarding its share price. I think the company should be making good money. Is there anything of major concern here (debt, balance sheet)? Would you consider it a HOLD? I'm bullish on precious metals.
Q: Ah! The widow and orphan stock.
What do you think? After all these years of never being able to gain traction, is now their time?
Just like nvdia when it did nothing for years and then became the darling of the street. Been burnt twice with Sierra but I sense a huge turnaround with 5G or a buyout!
Peter: your opinion! Thanks.
What do you think? After all these years of never being able to gain traction, is now their time?
Just like nvdia when it did nothing for years and then became the darling of the street. Been burnt twice with Sierra but I sense a huge turnaround with 5G or a buyout!
Peter: your opinion! Thanks.
-
Barclays Bank PLC ZC SP ETN REDEEM 08/09/2049 USD 50 (GRN)
-
KraneShares Global Carbon Strategy ETF (KRBN)
Q: Hi,
I am interested in investing in carbon credits. Do you have an opinion on the KRBN ETF and are you aware of any other investment vehicles in this space available to retail investors?
Thank you, Michael
I am interested in investing in carbon credits. Do you have an opinion on the KRBN ETF and are you aware of any other investment vehicles in this space available to retail investors?
Thank you, Michael
Q: What are your thoughts on Atomera? Would you consider them a buy at current prices?
Q: I had asked a question last week about NCU, but it seems to have been missed. Can I get your opinion on the latest NCU press release where they are consolidating shares 10:1? Was this necessary or a good/bad move by NCU? Why does a company consolidate shares?
Thanks
Thanks
Q: Read in the Post recently that BMO and NA may be best positioned to increase dividends, while BNS may not. Is that also your consensus, and also possibly the reason for the slow decline in BNS ?
Thanks as always
Thanks as always
Q: Shares lock-up expiry ? Hold or sell ?
Q: Over the next 5 to 10 years, which index do you expect to perform better? The S&P500 or the NASDAQ100 and what would be your reasoning? Thanks in advance.
Q: Can I please have your comments on this company for a long-term holding? Is it a good time to initiate a position today if so? Thank you as always.
Q: Hello 5i
We have 1.7 million in our invest accounts
500 thousand in rrsp
450 thousand in bonds and cash
The balance in 37 companies and 2 etf in a non register account
In a previous question you answer that
20 companies is about about the right number
Should We be reducing the number of companies we own
Thanks for the help
We have 1.7 million in our invest accounts
500 thousand in rrsp
450 thousand in bonds and cash
The balance in 37 companies and 2 etf in a non register account
In a previous question you answer that
20 companies is about about the right number
Should We be reducing the number of companies we own
Thanks for the help